nejm semaglutide cardiovascular VisualAbstract: and Outcomes in Obesity without Diabetes GLP-1 receptor agonists can reduce

Mattioli Introduction GLP-1 agonists like liraglutide have become a powerful tool for weight management, but they often come with digestive side effects and concerns about long-term use

Researchers explore the micronutrient composition and sufficiency of four versions of the carnivore diet as compared to national nutrient reference values.

There is no high-quality evidence documenting menstrual cycle alterations as a recognized adverse effect of semaglutide (Wegovy)

Since 2021, GLP-1s have eroded metformin as the preferred first-line therapy for many patients, despite metformins lower cost and oral administration

Tirzepatide 15 mg produced similar weight loss results as bariatric surgery among patients with obesity but had a favorable safety profile, according to a presenter at the ACG Annual Scientific Meeting

Coby Health review: we scored it 3.7/5 a competitive option